background
aim
coronaviru
diseas
caus
character
pandem
caus
seriou
public
health
challeng
world
larg
group
patient
infect
hbv
report
worldwid
especi
china
order
answer
whether
specif
treatment
strategi
patient
coinfect
hbv
requir
profound
understand
clinic
characterist
patient
howev
impact
infect
hbv
patient
remain
larg
unknown
retrospect
investig
includ
patient
admit
zhongnan
hospit
wuhan
univers
wuhan
china
januari
march
enrol
patient
laboratori
confirm
pneumonia
case
accord
criteria
report
previous
total
patient
analyz
clinic
record
laboratori
result
includ
diagnosi
hbv
infect
liver
function
among
confirm
patient
mean
age
year
old
femal
fifteen
previous
hbv
infect
patient
male
patient
hbv
infect
appear
higher
incid
liver
cirrhosi
increas
level
total
bilirubin
seven
patient
hbv
infect
defin
sever
case
sever
rate
patient
without
hbv
infect
mortal
patient
hbv
infect
compar
patient
without
hbv
infect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
conclus
infect
may
caus
live
function
damag
case
patient
hbv
infect
like
sever
diseas
outcom
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
earli
decemb
outbreak
novel
coronavirusassoci
pneumonia
wuhan
china
viru
spread
rapidli
citi
china
accumul
case
report
come
day
accord
announc
world
health
organ
diseas
offici
name
coronaviru
etiolog
diseas
identifi
novel
name
sever
acut
respiratori
syndrom
coronaviru
base
phylogenet
relationship
sarscov
march
declar
outbreak
pandem
far
peopl
countri
territori
report
case
peopl
die
accord
data
http
around
case
report
wuhan
china
addit
recent
emerg
hepat
b
viru
hbv
one
virus
caus
global
infect
threat
public
health
worldwid
preval
hbsag
high
million
patient
suffer
chronic
hbv
infect
patient
die
hbv
infect
due
liver
failur
liver
cirrhosi
hepatocellular
carcinoma
hcc
year
accord
nationwid
epidemiolog
survey
popul
whose
age
rang
china
preval
hbsag
around
million
patient
posit
hbv
infect
million
patient
diagnos
chronic
hepat
b
infect
previou
studi
shown
capac
infect
multipli
organ
includ
upper
respiratori
tract
lung
kidney
probabl
due
express
receptor
angiotensinconvert
enzym
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
tissu
recent
research
demonstr
infect
associ
live
function
damag
take
consider
larg
group
peopl
hbv
infect
risk
infect
patient
hbv
infect
requir
assess
order
design
specif
treatment
strategi
howev
impact
infect
hbv
patient
still
clear
exampl
yet
know
whether
infect
sever
hbv
patient
also
much
knowledg
impact
cours
hbv
infect
retrospect
studi
discov
liver
impair
common
featur
patient
high
patient
hbv
infect
develop
sever
situat
cours
infect
suggest
patient
hbv
infect
might
vulner
group
infect
januari
februari
patient
enrol
studi
inform
consent
obtain
patient
upon
admiss
depart
infecti
diseas
zhongnan
hospit
wuhan
univers
wuhan
china
clinic
outcom
ie
discharg
mortal
hospit
stay
monitor
march
final
date
followup
inform
enrol
patient
includ
demograph
inform
clinic
manifest
laboratori
data
includ
blood
routin
examin
liver
function
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
hepat
b
viru
serolog
marker
hbsag
antihbsag
hbeag
antihbeag
antihbcag
hbvdna
outcom
diseas
collect
review
two
research
avoid
subject
bias
diagnosi
base
realtim
rtpcr
throat
swab
sampl
collect
extract
rna
patient
suspect
infect
describ
anywher
diagnost
criteria
realtim
rtpcr
base
recommend
nation
statist
analys
studi
perform
spss
softwar
packag
util
test
fisher
exact
test
categor
variabl
normal
distribut
ttest
appli
analyz
data
express
mean
standard
deviat
regard
nonnorm
distribut
data
use
mann
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
whitney
u
test
result
shown
median
interquartil
rang
iqr
p
valu
consid
statist
signific
studi
approv
ethic
board
zhongnan
hospit
wuhan
univers
wuhan
china
total
patient
enrol
studi
includ
male
femal
around
patient
also
suffer
hbv
infect
male
take
patient
coinfect
hbv
seem
higher
coinfect
rate
compar
femal
tabl
median
age
total
enrol
patient
year
iqr
rang
year
common
symptom
onset
ill
fever
c
fatigu
cough
myalgia
less
common
dyspnea
headach
diarrhea
among
patient
thirtyf
case
underli
least
one
comorbid
hypertens
cardiovascular
diseas
diabet
malign
copd
liver
cirrhosi
patient
hbv
infect
higher
rate
liver
cirrhosi
tabl
seven
patient
hbv
infect
develop
sever
situat
percentag
sever
case
much
less
patient
without
hbv
infect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
treatment
mainli
support
care
tabl
seventyfour
patient
given
antivir
arbidol
oral
mg
three
time
per
day
oxygen
support
antibiot
therapi
oral
intraven
given
describ
tabl
sixtyon
patient
receiv
corticosteroid
suppress
excess
inflammatori
activ
signific
differ
treatment
patient
without
hbv
infect
biochem
test
includ
measur
level
alanin
aminotransferas
alt
aspart
aminotransferas
ast
total
bilirubin
tbil
gammaglutamyltransferas
ggt
alkalin
phosphatas
alp
albumin
well
record
prothrombin
time
activ
partial
thromboplastin
time
intern
normal
ratio
ddimer
creatinin
biochem
featur
found
normal
howev
level
total
bilirubin
higher
patient
hbv
infect
tabl
blood
count
patient
without
hbv
infect
show
lymphopenia
l
fifteen
patient
examin
hbsag
posit
femal
male
data
antihbsag
hbeag
antihbeag
antihbcag
avail
patient
ten
patient
hbeag
negtiv
one
posit
valu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
hbvdna
collect
patient
hbvdna
level
patient
iuml
tabl
observ
clinic
outcom
patient
within
day
treatment
eleven
patient
hbv
infect
patient
without
hbv
infect
discharg
hospit
accord
guidelin
two
patient
hbv
infect
patient
without
hbv
infect
still
hospit
two
patient
hbv
infect
patient
without
hbv
infect
dead
patient
hbv
infect
show
higher
mortal
rate
compar
patient
without
hbv
infect
vs
tabl
resembl
two
coronavirus
sarscov
merscov
caus
patient
sever
respiratori
symptom
even
lead
death
averag
mortal
rate
accord
data
report
though
case
acut
resolv
fast
liver
damag
identifi
around
patient
suffer
sar
viral
rna
detect
rtpcr
liver
tissu
provid
evid
sarscov
involv
liver
injur
liver
impair
also
report
mer
patient
accord
clinic
report
differ
center
larg
scale
case
sar
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
found
associ
damag
dysfunct
liver
tissu
case
show
liver
function
damag
abnorm
level
alanin
aminotransferas
alt
aspart
aminotransferas
ast
studi
line
previou
observ
found
case
without
hbv
infect
patient
dysfunct
liver
symptom
measur
level
alt
ast
tbil
ggt
alp
diseas
progress
enrol
case
also
discov
higher
incid
abnorm
liver
function
sever
patient
mild
case
data
shown
agre
studi
lower
incid
ast
abnorm
found
case
diagnos
ct
scan
subclin
stage
patient
confirm
onset
symptom
therefor
liver
function
could
consid
one
factor
indic
progress
accord
studi
case
around
confirm
patient
least
one
comorbid
among
preexist
chronic
diseas
abnorm
liver
function
one
common
featur
patient
sever
patient
like
hbv
infect
research
one
five
sever
patient
found
coinfect
hbv
infect
suggest
liver
impair
patient
could
due
viru
direct
attack
result
caus
drug
toxic
system
inflamm
detect
viral
rna
viral
particl
liver
biopsi
patient
help
elucid
viru
infect
liver
tissu
result
point
high
around
hbv
patient
identifi
sever
case
like
hbv
patient
suffer
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
sever
situat
diseas
progress
encount
infect
enrol
case
two
patient
sarscov
hbv
coinfect
die
admiss
one
patient
die
sever
liver
diseas
haptic
sclerosi
die
intestin
hemorrhag
seem
associ
impair
gastrointestin
tract
coinfect
case
analysi
requir
understand
whether
infect
agger
progress
preexist
diseas
therebi
caus
death
differ
phase
hbv
chronic
infect
includ
immunotoler
viral
suppress
longterm
treatment
nucleotid
analogu
current
studi
collect
data
hbv
coinfect
patient
one
time
point
mainli
use
identifi
hbv
infect
coinfect
case
analysi
requir
provid
evid
evalu
effect
infect
activ
hbv
replic
live
impair
differ
time
point
hbv
patient
differ
phase
conclus
respect
analyz
patient
coinfect
hbv
found
patient
preexist
hbv
infect
much
vulner
infect
pandem
infect
hbv
patient
given
specif
protect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
l
k
h
j
e
e
r
h
l
b
l
w
l
q
e
l
l
u
h
n
l
j
l
n
l
j
h
n
e
l
h
p
h
l
g
f
l
e
e
r
e
p
r
r
n
r
e
c
r
n
v
r
u
e
r
c
v
n
f
e
c
n
c
l
n
c
p
h
l
g
c
l
n
u
l
r
r
u
c
u
r
l
u
h
p
h
l
g
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
